Cancer Drug Safety and Public Health Policy: A Changing Landscape (Cancer Treatment and Research, 184)

Name: Cancer Drug Safety and Public Health Policy: A Changing Landscape (Cancer Treatment and Research, 184)
SKU: 133869
Price: 6 USD
Availability: InStock

6 $

Format : Publisher PDF

File Size : 2.5 MB

Category: ONCOLOGY BOOKS

Description

Cancer Drug Safety and Public Health Policy: A Changing Landscape (Cancer Treatment and Research, 184)

By Charles Bennett, Courtney Lubaczewski, Bartlett Witherspoon

When it comes to health policy, staying informed and up to date is of utmost importance. In the dynamic field of cancer drug safety, understanding recent developments and current trends is essential for healthcare professionals, policy makers, and researchers. That’s where the book “Recent Developments in Cancer Drug Safety: Implications for Health Policy” by Charles Bennett, Courtney Lubaczewski, and Bartlett Witherspoon comes in. This comprehensive and insightful book offers a detailed analysis of the ever-evolving landscape of cancer drug safety, providing readers with valuable knowledge and insights.

Pharmacovigilance, the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problem, is a vital aspect of healthcare. In the context of cancer blockbuster drugs, the authors discuss general considerations and efforts to develop a structured framework for the identification and reporting of adverse drug reactions (ADRs). Understanding the challenges and strategies for monitoring ADRs is crucial for healthcare professionals and policymakers alike.

The book delves into a number of important examples of serious ADRs to hematology and oncology drugs. These case studies provide valuable insights into the lessons learned and the policy implications of the legal cases that followed. By examining the settlements and the resulting changes in policies, the authors shed light on the dynamic nature of cancer drug safety and how it shapes the healthcare landscape.

One significant challenge in reporting blockbuster drug side effects is the difficulty of disseminating information through traditional medical literature. The book explores this issue through an empirical study, highlighting the barriers and potential solutions to improve reporting and ensure that relevant information reaches healthcare professionals, researchers, and patients.

Advancements in analytic methods for identifying ADRs have made significant contributions to pharmacovigilance. The authors pay particular attention to the value of optimal discriminant analysis in this context. By showcasing the potential of these methods, the book equips readers with tools to better identify and analyze ADRs, ultimately leading to improved health outcomes and patient safety.

In recent years, substantial fines have been imposed under the U.S. False Claims Act concerning the defrauding of governmental programs. The book explores the impacts of these fines on pharmacovigilance and drug safety. By examining the changing landscape as a result of these fines, the authors highlight the importance of maintaining high standards of pharmaceutical safety and integrity.

Published by Springer, the book “Recent Developments in Cancer Drug Safety: Implications for Health Policy” is an essential resource for healthcare professionals, researchers, policymakers, and all those interested in staying informed about the latest advancements and trends in cancer drug safety. With its thorough analysis, case studies, and emphasis on policy implications, this book provides a comprehensive understanding of the subject.

Product Details

Publisher: Springer; 1st ed. 2022 edition (December 1, 2022)
Language: English
Format: eBook Digital
Pages: 178
ISBN-10: 3031044010
ISBN-13: 978-3031044014

Order your copy of “Recent Developments in Cancer Drug Safety: Implications for Health Policy” today and gain valuable insights into the fast-evolving field of cancer drug safety. Stay informed, make informed decisions, and contribute to improving patient safety and well-being.